Covered recipient · General Payments record
JEFFREY PANTING CRESPO
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$3,302.51
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $446.47 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $294.42 | 8 |
| Lilly USA, LLC | $46.90 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $43.65 | 2 |
| Novo Nordisk AS | $29.72 | 2 |
| Acerta Pharma LLC | $19.00 | 1 |
| GlaxoSmithKline, LLC. | $12.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.00 | 02/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998068101 | CMS |
| ABBVIE INC. | $5.75 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998068103 | CMS |
| ABBVIE INC. | $99.49 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998068105 | CMS |
| ABBVIE INC. | $8.52 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998068107 | CMS |
| ABBVIE INC. | $125.58 | 07/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998068109 | CMS |
| ABBVIE INC. | $8.65 | 08/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998068111 | CMS |
| ABBVIE INC. | $10.76 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998068113 | CMS |
| ABBVIE INC. | $14.67 | 11/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998068115 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.00 | 11/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011670497 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $26.80 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000828574 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.85 | 05/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000826713 | CMS |
| GlaxoSmithKline, LLC. | $12.78 | 12/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002424731 | CMS |
| Lilly USA, LLC | $13.71 | 08/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031672459 | CMS |
| Lilly USA, LLC | $16.03 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031492767 | CMS |
| Lilly USA, LLC | $17.16 | 11/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031672453 | CMS |
| Novo Nordisk Inc | $15.43 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002983069 | CMS |
| Novo Nordisk Inc | $14.29 | 11/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002983053 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.